Vanda Pharmaceuticals Files 8-K
Ticker: VNDA · Form: 8-K · Filed: Apr 3, 2024 · CIK: 1347178
| Field | Detail |
|---|---|
| Company | Vanda Pharmaceuticals Inc. (VNDA) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Vanda Pharma filed an 8-K on April 3rd for events on April 2nd - check the full filing for details.
AI Summary
Vanda Pharmaceuticals Inc. filed an 8-K on April 3, 2024, reporting on events that occurred on April 2, 2024. The filing primarily concerns other events and includes financial statements and exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates Vanda Pharmaceuticals is providing updates to the SEC, which could contain material information for investors. The specific nature of the 'Other Events' requires further review of the full document.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific financial or operational details that would indicate immediate risk.
Key Players & Entities
- Vanda Pharmaceuticals Inc. (company) — Registrant
- 20240403 (date) — Filing Date
- 20240402 (date) — Earliest Event Date
- 20240403 (date) — Date as of Change
FAQ
What specific 'Other Events' are being reported by Vanda Pharmaceuticals in this 8-K filing?
The provided excerpt does not detail the specific 'Other Events'; the full filing must be reviewed for this information.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on April 2, 2024.
What is Vanda Pharmaceuticals Inc.'s principal executive office address?
Vanda Pharmaceuticals Inc.'s principal executive office is located at 2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037.
What is Vanda Pharmaceuticals Inc.'s telephone number?
Vanda Pharmaceuticals Inc.'s telephone number is (202) 734-3400.
What is the SEC file number for Vanda Pharmaceuticals Inc.?
The SEC file number for Vanda Pharmaceuticals Inc. is 001-34186.
Filing Stats: 465 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-04-03 16:32:00
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share VNDA The Nasdaq Global Ma
Filing Documents
- d819383d8k.htm (8-K) — 24KB
- d819383dex991.htm (EX-99.1) — 33KB
- g819383g0404005146257.jpg (GRAPHIC) — 4KB
- 0001193125-24-086031.txt ( ) — 191KB
- vnda-20240402.xsd (EX-101.SCH) — 3KB
- vnda-20240402_lab.xml (EX-101.LAB) — 18KB
- vnda-20240402_pre.xml (EX-101.PRE) — 11KB
- d819383d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release of Vanda Pharmaceuticals Inc. dated April 2, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 3, 2024 VANDA PHARMACEUTICALS INC. By: /s/ Timothy Williams Name: Timothy Williams Title: Senior Vice President, General Counsel and Secretary